165 related articles for article (PubMed ID: 31213833)
1.
Jiao Y; Li Y; Liu S; Chen Q; Liu Y
Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833
[No Abstract] [Full Text] [Related]
2.
Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
Front Oncol; 2021; 11():658547. PubMed ID: 34094951
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer.
Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J
Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer.
Ma JJ; Xiang C; Zhu HQ; Bai BL; Wang P; Zhao GA
Heliyon; 2024 Jan; 10(1):e23163. PubMed ID: 38163190
[TBL] [Abstract][Full Text] [Related]
5. Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
Jiao Y; Fu Z; Li Y; Zhang W; Liu Y
PLoS One; 2019; 14(1):e0211291. PubMed ID: 30695070
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
7. Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer.
Xing J; Tian Y; Ji W; Wang X
Medicine (Baltimore); 2020 Feb; 99(9):e19230. PubMed ID: 32118724
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Jiao Y; Li Y; Ji B; Cai H; Liu Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
[TBL] [Abstract][Full Text] [Related]
9. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.
Li D; Xu J; Dong X; Chen W; Pan L; Jiang H; Pan J; Huang Y
J Gastrointest Oncol; 2021 Aug; 12(4):1374-1383. PubMed ID: 34532095
[TBL] [Abstract][Full Text] [Related]
11. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
[No Abstract] [Full Text] [Related]
12. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
Zhang Y; Zhang Y; Wang J; Yang J; Yang G
Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
14. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis.
Zheng X; Du Y; Liu M; Wang C
Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
17. PGM5: a novel diagnostic and prognostic biomarker for liver cancer.
Jiao Y; Li Y; Jiang P; Han W; Liu Y
PeerJ; 2019; 7():e7070. PubMed ID: 31218127
[TBL] [Abstract][Full Text] [Related]
18. LUM Expression and Its Prognostic Significance in Gastric Cancer.
Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
Front Oncol; 2020; 10():605. PubMed ID: 32500021
[No Abstract] [Full Text] [Related]
19. Expression of eukaryotic translation initiation factor 3 subunit B in liver cancer and its prognostic significance.
Yue Q; Meng L; Jia B; Han W
Exp Ther Med; 2020 Jul; 20(1):436-446. PubMed ID: 32537008
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Lin M; Li Y; Qin S; Jiao Y; Hua F
Oncol Lett; 2020 Apr; 19(4):2773-2784. PubMed ID: 32218830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]